Our Member Services Representatives are unavailable Friday, April 10, due to the holiday.

 

CORONAVIRUS (COVID-19)

Resources on COVID-19 and how BCBSND is responding to help protect all North Dakotans

Treatment of Hyperhidrosis

Effective Date: November 01, 2019
Revised Date: October 09, 2019
Last Reviewed: September 26, 2019

Description

Hyperhidrosis is the secretion of sweat in the amounts greater than physiologically needed for thermoregulation.

It is most commonly a chronic idiopathic (primary) condition; however, secondary medical conditions or medications should be excluded.

Criteria

General medical necessity criteria for the treatment of primary focal hyperhidrosis.

Treatment for primary focal hyperhidrosis may be considered medically necessary when ANY ONE of the following general criteria have been met:

  • Acrocyanosis of the hands; or
  • History of recurrent skin maceration with bacterial or fungal infections (including, but not limited to, cutaneous disorders such as dermatophytosis (ringworm), pitted keratolysis, and/or viral warts at the sites of hyperhidrosis); or
  • History of atopic dermatitis (atopic eczema) in spite of medical treatments with topical dermatological or systemic anticholinergic agents; and 

BOTH of the following criteria must be met:

  • Unresponsive to or unable to tolerate pharmacotherapy modalities prescribed for excessive sweating (including, but not limited to, anti-cholinergics, beta-blockers, or benzodiazepines); and
  • Topical 20% aluminum chloride or other extra-strength antiperspirants are ineffective or result in a severe rash.

Treatment of Hyperhidrosis not meeting the criteria above will be considered not medically necessary.

Procedure Codes

17999 32664 64650 64653 69676 97033 J0585

Criteria for specific focal regions

ANY ONE of the following treatments may be considered medically necessary for the corresponding focal regions ONLY when the general criteria outlined above has been met.

Axillary Region

  • Botulinum Toxin A (Onabotulinumotixin A) for severe primary axillary hyperhidrosis that is inadequately managed with topical agents, in individuals 18 years and older; or
  • Iotophoresis; or
  • Endoscopic Transthoracic Sympathectomy (ETS) and surgical excision of axillary sweat glands, if conservative treatment (i.e., aluminum chloride or botulinum toxin, individually, and in combination) has failed.

Note: Sympathectomy for hyperhidrosis treatment of axillary and palmar regions requires an inpatient stay.

Initial authorization for botulinum toxin A (OnabotulinumtoxinA) for axillary hyperhidrosis will expire in 3 months from the original authorization date for any diagnosis. Additional authorization may be given if documentation of an objective measurable effect is provided indicating clinical improvement of the condition. Absence of clinical improvement of axillary hyperhidrosis  will be considered not medically necessary for further injections of botulinum toxin A (Onabotulinumtoxin A).

Procedure codes

32664 64650 97033 J0585

Axillary liposuction, radiofrequency ablation and microwave treatment for axillary hyperhidrosis are considered experimental/investigational and therefore non-covered.  Scientific evidence does not demonstrate the effectiveness of these treatments.

Treatment of axillary hyperhidrosis not meeting the criteria above will be considered not medically necessary.

Procedure codes

15878 17999

Palmar Region

  • Botulinum Toxin A (Onabotulinumtoxin A) for severe primary palmar hyperhidrosis that is inadequately managed with topical agents, in individuals 18 years and older; or

Note: Injections should occur no sooner than 6 months apart.

  • Iontophoresis; or
  • ETS, if conservative treatment (i.e., aluminum chloride or botulinum toxin type A, individually and in combination) has failed.

Procedure Codes

32664 64653 97033 J0585

Botulinum toxin B (Rimabotulinumtoxin B), microwave treatment, and radiofrequency ablation for palmar hyperhidrosis are considered experimental/investigational and therefore non-covered.  Scientific evidence does not demonstrate the effectiveness of these treatments.

Treatment of palmar hyperhidrosis not meeting the criteria above will be considered not medically necessary.

Procedure Codes

17999 J0587

Plantar Region

  • Iontophoresis.

Procedure Codes

97033

Botulinum toxin, lumbar sympathectomy, radiofrequency ablation, and microwave treatment for plantar hyperhidrosis are considered experimental/investigational and therefore non-covered.  Scientific evidence does not demonstrate the effectiveness of these treatments.

Treatment of plantar hyperhidrosis not meeting the criteria above will be considered not medically necessary.

Procedure Codes

17999 64653 64818 J0585 J0587

Craniofacial Region

  • ETS, if conservative treatment (e.g., aluminum chloride) has failed.

Procedure Codes

32664

Botulinum toxin, iontophoresis, radiofrequency ablation, and microwave treatment for craniofacial hyperhidrosis are considered experimental/investigational and therefore non-covered. Scientific evidence does not demonstrate the effectiveness of these treatments.

Treatment of craniofacial hyperhidrosis not meeting the criterial above will be considered not medically necessary.

Procedure Codes

17999 64653 97033 J0585 J0587

Secondary Hyperhidrosis:  Secondary Gustatory Hyperhidrosis

The following treatment may be considered medically necessary for severe gustatory hyperhidrosis when the above general criteria have been met:

  • Surgical options (e.g., Tympanic neurectomy, if conservative treatment has failed.

Procedure Codes

69676

Botulinum toxin and iontophoresis for severe gustatory hyperhidrosis are considered experimental/investigational and therefore non-covered.  Scientific evidence does not demonstrate the effectiveness of these treatments.

Treatment of secondary hyperhidrosis not meeting the criteria above will be considered not medically necessary.

Procedure Codes

64653 97033 J0585 J0587

Diagnosis Codes

Covered Diagnosis codes for Procedure Codes: J0585          

L74.510 L74.512

Covered Diagnosis codes for Procedure Codes: 64650

L74.510

Covered Diagnosis codes for Procedure Codes: 64653     

L74.512

Covered Diagnosis codes for Procedure Codes: 97033

L74.510 L74.512 L74.513

Covered Diagnosis codes for Procedure Codes: 32664

L74.510 L74.511 L74.512

Covered Diagnosis for Procedure Codes: 69676

L74.52

Non-Covered Diagnosis Codes for Procedure Codes: 15877, 15878, 17999

L74.52 L74.510 L74.511 L74.512 L74.513  L74.519

Links